Comparison of Loading Strategies With Antiplatelet Drugs in Patients Undergoing Elective Coronary Intervention (SASSICAIA)
Intensified Loading With Prasugrel Versus Standard Loading With Clopidogrel in Invasive-treated Patients With Biomarker-Negative Angina Pectoris
Sponsor: LMU Klinikum
Terminated
Due to low recruitment
Other Angina Pectoris trials with similar outcome
This PHASE4 trial investigates Angina Pectoris and is currently terminated or withdrawn. LMU Klinikum leads this study, which shows 13 recorded versions since 2015 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Oct 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Oct 2021 [monthly]
Terminated PHASE4
▶ Show 8 earlier versions
-
Aug 2020 — Jan 2021 [monthly]
Terminated PHASE4
-
Mar 2020 — Aug 2020 [monthly]
Terminated PHASE4
Status: Active Not Recruiting → Terminated
-
Feb 2019 — Mar 2020 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Sep 2018 — Feb 2019 [monthly]
Recruiting PHASE4
-
Jun 2018 — Sep 2018 [monthly]
Recruiting PHASE4
-
Apr 2018 — Jun 2018 [monthly]
Recruiting PHASE4
-
Apr 2017 — Apr 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Apr 2017 [monthly]
Recruiting PHASE4
First recorded
Sep 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- LMU Klinikum
For direct contact, visit the study record on ClinicalTrials.gov .